New ultrasound could spare patients unnecessary pancreatic surgery

NCT ID NCT07657884

First seen Jun 25, 2026 · Last updated Jun 25, 2026

Summary

This study tests whether a new ultrasound technique called SMI can accurately identify benign pancreatic cysts (serous cystadenomas). Currently, many patients with these harmless cysts undergo unnecessary surgery due to diagnostic uncertainty. The study will enroll 60 patients and compare SMI results with the current gold-standard test. If SMI works well, it could provide a safer, cheaper, and non-invasive way to diagnose these cysts.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEROUS CYSTADENOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hôpital Privé Jean Mermoz

    RECRUITING

    Lyon, 69008, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

SMI (Superb Vascular Imaging) ultrasound

What this could lead to

If successful, SMI could become a safe, non-invasive way to diagnose benign pancreatic cysts, avoiding risky surgeries.

What could go wrong

This is a small, early-stage study with no published data yet. SMI may not be accurate enough to replace current methods.

Conditions

The condition(s) this trial relates to.

Cystadenoma, Serous

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.